{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:41:20Z","timestamp":1776400880006,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00380-019-01370-9","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T07:25:01Z","timestamp":1551857101000},"page":"1533-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study"],"prefix":"10.1007","volume":"34","author":[{"given":"Monami","family":"Ando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuya","family":"Inden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Sairaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuho","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"1370_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Ha\u00efssaguerre","year":"1998","unstructured":"Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le M\u00e9tayer P, Cl\u00e9menty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659\u2013666","journal-title":"N Engl J Med"},{"key":"1370_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castell\u00e1 M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Alexandru Popescu B, Schotten U, Van Putte B, Vardas P (2016) ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO). Eur Heart J 37:2893\u20132962","journal-title":"Eur Heart J"},{"key":"1370_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCEP.114.001473","volume":"7","author":"A Metzner","year":"2014","unstructured":"Metzner A, Reissmann B, Rausch P, Mathew S, Wohlmuth P, Tilz R, Rillig A, Lemes C, Deiss S, Heeger C, Kamioka M, Lin T, Ouyang F, Kuck KH, Wissner E (2014) One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 7:288\u2013292","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1370_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"KH Kuck","year":"2016","unstructured":"Kuck KH, Brugada J, F\u00fcrnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, Investigators FIREANDICE (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235\u20132245","journal-title":"N Engl J Med"},{"key":"1370_CR5","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1253\/circj.CJ-16-0285","volume":"80","author":"K Okumura","year":"2016","unstructured":"Okumura K, Matsumoto K, Kobayashi Y, Nogami A, Hokanson RB, Kueffer F (2016) Safety and efficacy of cryoballoon Ablation for paroxysmal atrial fibrillation in Japan\u2014results from the Japanese prospective post-market surveillance study. Circ J 80:1744\u20131749","journal-title":"Circ J"},{"key":"1370_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857\u2013867","journal-title":"Ann Intern Med"},{"key":"1370_CR7","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"L Biase Di","year":"2014","unstructured":"Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A (2014) Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation 129:2638\u20132644","journal-title":"Circulation"},{"key":"1370_CR8","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","volume":"36","author":"R Cappato","year":"2015","unstructured":"Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, Ma CS, Hess S, Wells DS, Juang G, Vijgen J, H\u00fcgl BJ, Balasubramaniam R, De Chillou C, Davies DW, Fields LE, Natale A, Investigators VENTURE-AF (2015) Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J 36:1805\u20131811","journal-title":"Eur Heart J"},{"key":"1370_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","volume":"12","author":"L Biase Di","year":"2015","unstructured":"Di Biase L, Lakkireddy D, Trivedi C, Deneke T, Martinek M, Mohanty S, Mohanty P, Prakash S, Bai R, Reddy M, Gianni C, Horton R, Bailey S, Sigmund E, Derndorfer M, Schade A, Mueller P, Szoelloes A, Sanchez J, Al-Ahmad A, Hranitzky P, Gallinghouse GJ, Hongo RH, Beheiry S, P\u00fcrerfellner H, Burkhardt JD, Natale A (2015) Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study. Heart Rhythm 12:1162\u20131168","journal-title":"Heart Rhythm"},{"key":"1370_CR10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","volume":"376","author":"H Calkins","year":"2017","unstructured":"Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M, Investigators RE-CIRCUIT (2017) Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med 376:1627\u20131636","journal-title":"N Engl J Med"},{"key":"1370_CR11","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","volume":"39","author":"P Kirchhof","year":"2018","unstructured":"Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, Fetsch T, Van Gelder IC, Gentlesk P, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi HR, Massaro T, Mont L, Nielsen JC, N\u00f6lker G, Piccini JP, De Potter T, Scherr D, Schotten U, Themistoclakis S, Todd D, Vijgen J, Di Biase L (2018) Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J 39:2942\u20132955","journal-title":"Eur Heart J"},{"key":"1370_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","volume":"4","author":"MR Reynolds","year":"2018","unstructured":"Reynolds MR, Allison JS, Natale A, Weisberg IL, Ellenbogen KA, Richards M, Hsieh WH, Sutherland J, Cannon CP (2018) A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial. JACC Clin Electrophysiol 4:580\u2013588","journal-title":"JACC Clin Electrophysiol"},{"key":"1370_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pace.12553","volume":"38","author":"T Nagao","year":"2015","unstructured":"Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, Ishikawa S, Miyoshi A, Okumura S, Ohguchi S, Yamamoto T, Yoshida N, Hirai M, Murohara T (2015) Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation. Pacing Clin Electrophysiol 38:155\u2013163","journal-title":"Pacing Clin Electrophysiol"},{"key":"1370_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2169\/internalmedicine.54.3520","volume":"54","author":"T Nagao","year":"2015","unstructured":"Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, Ishikawa S, Miyoshi A, Okumura S, Ohguchi S, Yamamoto T, Yoshida N, Hirai M, Murohara T (2015) Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation. Intern Med 54:1167\u20131173","journal-title":"Intern Med"},{"key":"1370_CR15","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1253\/circj.CJ-17-1114","volume":"82","author":"T Kojima","year":"2018","unstructured":"Kojima T, Fujiu K, Fukuma N, Matsunaga H, Oshima T, Matsuda J, Matsubara T, Shimizu Y, Oguri G, Hasumi E, Morita H, Komuro I (2018) Periprocedural complications in patients undergoing catheter ablation of atrial fibrillation without discontinuation of a vitamin K antagonist and direct oral anticoagulants. Circ J 82:1552\u20131557","journal-title":"Circ J"},{"key":"1370_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"1370_CR17","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1253\/circj.CJ-10-1183","volume":"75","author":"S Ogawa","year":"2011","unstructured":"Ogawa S, Shinohara Y, Kanmuri K (2011) Safety and efficacy of the oral direct factor Xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation\u2014the ARISTOTLE-J study. Circ J 75:1852\u20131859","journal-title":"Circ J"},{"key":"1370_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1373\/clinchem.2009.133801","volume":"56","author":"AK Saenger","year":"2010","unstructured":"Saenger AK, Christenson RH (2010) Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 56:21\u201333","journal-title":"Clin Chem"},{"key":"1370_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/01.STR.0000209240.63821.1a","volume":"37","author":"M Barber","year":"2006","unstructured":"Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ (2006) d-Dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays. Stroke 37:1113\u20131115","journal-title":"Stroke"},{"key":"1370_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/STROKEAHA.108.516377","volume":"40","author":"DT Laskowitz","year":"2009","unstructured":"Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC, BRAIN Study Group (2009) Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 40:77\u201385","journal-title":"Stroke"},{"key":"1370_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1253\/circj.CJ-66-0054","volume":"77","author":"JCS Joint Working Group","year":"2013","unstructured":"JCS Joint Working Group (2013) Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011)\u2014digest version. Circ J 77:249\u2013274","journal-title":"Circ J"},{"key":"1370_CR22","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1253\/circj.CJ-18-0398","volume":"82","author":"M Harada","year":"2018","unstructured":"Harada M, Koshikawa M, Motoike Y, Ichikawa T, Sugimoto K, Watanabe E, Ozaki Y (2018) Left atrial appendage thrombus prior to atrial fibrillation ablation in the era of direct oral anticoagulants. Circ J 82:2715\u20132721","journal-title":"Circ J"},{"key":"1370_CR23","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.hrthm.2015.03.021","volume":"12","author":"W Su","year":"2015","unstructured":"Su W, Kowal R, Kowalski M, Metzner A, Svinarich JT, Wheelan K, Wang P (2015) Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures. Heart Rhythm 12:1658\u20131666","journal-title":"Heart Rhythm"},{"key":"1370_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694","journal-title":"J Thromb Haemost"},{"key":"1370_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/pace.12036","volume":"36","author":"T Nin","year":"2013","unstructured":"Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Inden Y, Hirayama H, Murohara T (2013) A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation. Pacing Clin Electrophysiol 36:172\u2013179","journal-title":"Pacing Clin Electrophysiol"},{"key":"1370_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40261-013-0134-5","volume":"33","author":"A Sairaku","year":"2013","unstructured":"Sairaku A, Yoshida Y, Ando M, Hirayama H, Nakano Y, Kihara Y (2013) A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillation. Clin Drug Investing 33:847\u2013853","journal-title":"Clin Drug Investing"},{"key":"1370_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.amjcard.2014.05.038","volume":"114","author":"MR Aryal","year":"2014","unstructured":"Aryal MR, Ukaigwe A, Pandit A, Karmacharya P, Pradhan R, Mainali NR, Pathak R, Jalota L, Bhandari Y, Donato A (2014) Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol 114:577\u2013582","journal-title":"Am J Cardiol"},{"key":"1370_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/heartjnl-2013-304386","volume":"100","author":"R Provid\u00eancia","year":"2014","unstructured":"Provid\u00eancia R, Albenque JP, Combes S, Bouzeman A, Casteigt B, Combes N, Narayanan K, Marijon E, Boveda S (2014) Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Heart 100:324\u2013335","journal-title":"Heart"},{"key":"1370_CR29","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.hrthm.2015.04.016","volume":"12","author":"T Nagao","year":"2015","unstructured":"Nagao T, Inden Y, Yanagisawa S, Kato H, Ishikawa S, Okumura S, Mizutani Y, Ito T, Yamamoto T, Yoshida N, Hirai M, Murohara T (2015) Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation. Heart Rhythm 12:1972\u20131978","journal-title":"Heart Rhythm"},{"key":"1370_CR30","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/01.CIR.0000058706.82623.A1","volume":"107","author":"P Khairy","year":"2003","unstructured":"Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG, Santoianni D, Dubuc M (2003) Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 107:2045\u20132050","journal-title":"Circulation"},{"key":"1370_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jjcc.2016.04.009","volume":"69","author":"K Okishige","year":"2017","unstructured":"Okishige K, Nakamura T, Aoyagi H, Kawaguchi N, Yamashita M, Kurabayashi M, Suzuki H, Asano M, Shimura T, Yamauchi Y, Sasano T, Hirao K (2017) Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation. J Cardiol 69:11\u201315","journal-title":"J Cardiol"},{"key":"1370_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.hrthm.2018.07.011","volume":"16","author":"S Miyazaki","year":"2019","unstructured":"Miyazaki S, Kajiyama T, Yamao K, Hada M, Yamaguchi M, Nakamura H, Hachiya H, Tada H, Hirao K, Iesaka Y (2019) Silent cerebral events\/lesions after second-generation cryoballoon ablation: how can we reduce the risk of silent strokes? Heart Rhythm 16:41\u201348","journal-title":"Heart Rhythm"},{"key":"1370_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-158-5-201303050-00007","volume":"158","author":"S Kalantarian","year":"2013","unstructured":"Kalantarian S, Stern TA, Mansour M, Ruskin JN (2013) Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 158:338\u2013346","journal-title":"Ann Intern Med"},{"key":"1370_CR34","first-page":"1323","volume":"8","author":"GB Forleo","year":"2016","unstructured":"Forleo GB, Della Rocca DG, Lavalle C, Mantica M, Papavasileiou LP, Ribatti V, Panattoni G, Santini L, Natale A, Biase LD (2016) A patient with asymptomatic cerebral lesions during AF ablation: how much should we worry? J Atr Fibrillation 8:1323","journal-title":"J Atr Fibrillation"},{"key":"1370_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-170970","volume":"62","author":"M Ihara","year":"2018","unstructured":"Ihara M, Washida K (2018) Linking atrial fibrillation with Alzheimer\u2019s disease: epidemiological, pathological, and mechanistic evidence. J Alzheimers Dis 62:61\u201372","journal-title":"J Alzheimers Dis"},{"key":"1370_CR36","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.jacc.2009.12.049","volume":"55","author":"T Sadanaga","year":"2010","unstructured":"Sadanaga T, Sadanaga M, Ogawa S (2010) Evidence that d-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol 55:2225\u20132231","journal-title":"J Am Coll Cardiol"},{"key":"1370_CR37","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1160\/TH03-06-0363","volume":"90","author":"N Vene","year":"2003","unstructured":"Vene N, Mavri A, Kosmelj K, Stegnar M (2003) High d-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 90:1163\u20131172","journal-title":"Thromb Haemost"},{"key":"1370_CR38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","volume":"34","author":"Z Hijazi","year":"2013","unstructured":"Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L (2013) Biomarkers in atrial fibrillation: a clinical review. Eur Heart J 34:1475\u20131480","journal-title":"Eur Heart J"},{"key":"1370_CR39","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1161\/01.CIR.91.7.1929","volume":"91","author":"CB Granger","year":"1995","unstructured":"Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM, Califf RM (1995) Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91:1929\u20131935","journal-title":"Circulation"},{"key":"1370_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1046\/j.1365-2141.1996.d01-1499.x","volume":"92","author":"U Genewein","year":"1996","unstructured":"Genewein U, Haeberli A, Straub PW, Beer JH (1996) Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 92:479\u2013485","journal-title":"Br J Haematol"},{"key":"1370_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1185\/030079906X89801","volume":"22","author":"C Hermans","year":"2006","unstructured":"Hermans C, Claeys D (2006) Review of the rebound phenomenon in new anticoagulant treatments. Curr Med Res Opin 22:471\u2013481","journal-title":"Curr Med Res Opin"},{"key":"1370_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jvs.2010.02.275","volume":"52","author":"M Hoke","year":"2010","unstructured":"Hoke M, Koppensteiner R, Schillinger M, Haumer M, Minar E, Wiesbauer F, Huber CD, Mlekusch W (2010) d-Dimer testing in the diagnosis of transfemoral pseudoaneurysm after percutaneous transluminal procedures. J Vasc Surg 52:383\u2013387","journal-title":"J Vasc Surg"},{"key":"1370_CR43","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","volume":"373","author":"DM Siegal","year":"2015","unstructured":"Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA (2015) Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 373:2413\u20132424","journal-title":"N Engl J Med"},{"key":"1370_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10840-017-0274-2","volume":"49","author":"LC Brendel","year":"2017","unstructured":"Brendel LC, Dobler F, Hessling G, Michel J, Braun SL, Steinsiek AL, Groha P, Eckl R, Deisenhofer I, Hyseni A, Roest M, Ott I, Steppich B (2017) The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban. J Interv Card Electrophysiol 49:237\u2013244","journal-title":"J Interv Card Electrophysiol"}],"updated-by":[{"DOI":"10.1007\/s00380-019-01424-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T00:00:00Z","timestamp":1557705600000}}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01370-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:15:50Z","timestamp":1583367350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01370-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01370-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00380-019-01424-y","asserted-by":"object"}]},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article, the table\u00a02 was published incorrectly.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}